Table 4.

List of KEGG pathways enriched among the top 5 and 10 percent of genes in the resultant gene list

	Enrichment P-values
KEGG pathways	Top 5% of genes (1684)	Top 10% of genes (3368)
Adherens junction	5.42E–08	8.18E–07
Adipocytokine signaling pathway	4.43E–03	3.38E–09
Axon guidance	2.74E–11	7.72E–08
B-cell receptor signaling pathway	3.21E–06	1.47E–08
Calcium signaling pathway	1.02E–09	1.03E–11
Cell adhesion molecules (CAMs)	9.12E–09	5.02E–05
Cell cycle	1.67E–09	2.26E–04
Chronic myeloid leukemia	1.53E–05	4.53E–06
Colorectal cancer	6.16E–09	6.31E–08
Cytokine–cytokine receptor interaction	NE	1.05E–07
Focal adhesion	4.42E–09	4.96E–08
Gap junction	6.08E–08	4.57E–07
Glioma	3.24E–07	6.69E–06
GnRH signaling pathway	1.86E–11	3.67E–08
Huntington's disease	2.09E–07	8.18E–08
Insulin signaling pathway	8.06E–08	7.15E–08
Jak-signal transducer and activator of transcription (STAT) signaling pathway	7.35E–03	1.91E–06
Leukocyte trans-endothelial migration	1.38E–05	8.57E–08
Long-term depression	6.56E–08	7.13E–05
Long-term potentiation	9.80E–11	1.04E–05
MAPK signaling pathway	8.66E–15	1.43E–13
Natural killer cell-mediated cytotoxicity	1.07E–07	3.60E–14
Retroactive ligand–receptor interaction	NE	1.31E–07
Pancreatic cancer	1.97E–06	6.49E–07
Phosphatidyl-inositol signaling system	7.27E–06	1.31E–03
Regulation of actin cytoskeleton	1.13E–12	5.51E–10
T-cell receptor signaling pathway	4.48E–08	9.56E–12
Tight junction	6.36E–07	1.45E–04
Toll-like receptor signaling pathway	7.98E–05	1.73E–09
Wnt signaling pathway	1.07E–15	2.50E–09

NE, not enriched.